poisar

Stocks · News reference

Argus Research Maintains Buy Rating and Raises Price Target for Herbalife

Fiscal.ai

Argus Research analyst John Staszak has reiterated a 'Buy' rating on Herbalife (NYSE: HLF) and increased the price target from $15 to $20.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading